North Growth Management’s Zimmer Biomet ZBH Stock Holding History

North Growth Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-65,920	Closed	-$8.13M	–	55
2021 Q4	$8.13M	Sell	65,920 -20,600	-24%	-$2.7M	1.35%	35
2021 Q3	$12.3M	Buy	86,520 +1,030	+1%	+$152K	2.16%	19
2021 Q2	$13.4M	Hold	85,490	–	–	2.18%	18
2021 Q1	$13.3M	Hold	85,490	–	–	2.36%	15
2020 Q4	$12.8M	Sell	85,490 -7,210	-8%	-$1.02M	2.62%	11
2020 Q3	$12.2M	Hold	92,700	–	–	2.69%	13
2020 Q2	$10.7M	Sell	92,700 -3,090	-3%	-$356K	2.57%	15
2020 Q1	$9.35M	Buy	95,790 +6,180	+7%	+$810K	2.63%	13
2019 Q4	$13M	Hold	89,610	–	–	2.92%	11
2019 Q3	$11.9M	Hold	89,610	–	–	2.88%	11
2019 Q2	$10.2M	Hold	89,610	–	–	2.52%	18
2019 Q1	$11M	Hold	89,610	–	–	2.95%	9
2018 Q4	$8.97M	Hold	89,610	–	–	2.51%	18
2018 Q3	$11.4M	Hold	89,610	–	–	2.88%	12
2018 Q2	$9.64M	Buy	89,610 +11,330	+14%	+$1.23M	2.43%	19
2018 Q1	$8.23M	Hold	78,280	–	–	2.12%	22
2017 Q4	$9.11M	Buy	+78,280	New	+$8.85M	2.39%	22

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

North Growth Management's ZBH Position: Q1 2022 in Review

North Growth Management sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 65,920 shares — an estimated $8.13M sold.

North Growth Management first reported a position in ZBH in Q4 2017 and held it in 17 quarters. The position peaked at $13.4M in Q2 2021. 978 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

North Growth Management reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
North Growth Management sold 65,920 Zimmer Biomet shares in Q1 2022, an estimated $8.13M.
North Growth Management first reported a position in Zimmer Biomet in Q4 2017 and held it in 17 quarters.
North Growth Management's Zimmer Biomet position peaked at $13.4M in Q2 2021.
978 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on North Growth Management's 13F filing for Q1 2022, filed 14 Apr 2022.